Matt Standish is the founder and CEO of IDInteract, a company that plans to reinvent the way brands interact with customers online from its headquarters in Detroit.
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.